Lung Cancer Services
21 services found
by:Oncimmune Holdings PLC based inNottingham, UNITED KINGDOM
EarlyCDT is a simple blood test that detects the elevated presence of autoantibodies generated by the body's immune system as a natural defence against cancer cells. EarlyCDT Lung is the world’s most thoroughly validated blood test for the detection of lung cancer and requires only a small volume of blood which can be taken ...
Manufactured by:Alfa Chemistry based inNY, NEW YORK (USA)
PF-06821497 is a potent EZH2 Inhibitor which can be used for the treatment of relapsed/refractory SCLC (small cell lung cancer), castration resistant prostate cancer, and follicular lymphoma. Alfa Chemistry offers high quality of PF-06821497 which can be a potent EZH2 Inhibitor for the treatment of relapsed/refractory SCLC (small cell ...
by:Greensboro Radiology based inGreensboro, NORTH CAROLINA (USA)
Cardiothoracic Radiology encompasses all modes of imaging of the thorax including the chest, lungs and heart. Practitioners are responsible for all conventional chest radiography, CT and MRI. Greensboro Radiology is proud to offer sub-specialty trained Cardiothoracic expertise including high-resolution CT for interstitial lung disease as well as screening ...
Manufactured by:Alfa Chemistry based inNY, NEW YORK (USA)
Methotrexate, one of the earliest cancer chemotherapy agents, which is extensively used in the treatment of cancer, including breast cancer, leukemia, lung cancer, lymphoma, osteosarcoma and so on. The efficacy of methotrexate mainly due to its inhibitory effect on dihydrofolate reductase (DHFR)[1]. ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
The glycan head group determines the biological function of glycosphingolipids. Abnormal glycosylation of glycosphingolipids is closely related to various cancers, such as breast cancer, lung cancer, and brain tumors. Glycosphingolipid glycans are also involved in many cellular processes, such as signal transduction, receptor ...
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
Evaluation of a New Blood Test for Detecting Multiple Types of Cancer Early. The SUMMIT Study is a prospective, observational, longitudinal, cohort study being conducted in London in the United Kingdom. It is designed to enroll approximately 25,000 men and women age 50 to 77 years who do not have a cancer diagnosis at the time of enrollment. SUMMIT aims to ...
Manufactured by:Alfa Chemistry based inNY, NEW YORK (USA)
Ifosfamide has been effectively employed in the treatment of multiple cancers, including testicular cancer, soft tissue sarcoma, osteosarcoma, bladder cancer, small cell lung cancer, non-Hodgkin lymphoma, Hodgkin lymphoma, epithelial ovarian cancer, cervical carcinoma and germ cell carcinoma of ...
by:Lucence Health Inc. based inPalo Alto, CALIFORNIA (USA)
AmpliMark is the foundational technology behind Lucence’s liquid biopsy tests. AmpliMark uses unique molecular barcodes in this error-correction technology. It is designed to improve detection of multiple mutation types like single nucleotide variants, insertions and deletions (indels), copy number variations (CNVs), fusions and microsatellite instability ...
Manufactured by:MiraDx based inLos Angeles, CALIFORNIA (USA)
Independent of their BRCA1/BRCA2 mutational status, ...
Manufactured by:Galera Therapeutics, Inc. based inMalvern, PENNSYLVANIA (USA)
Harnessing the Anticancer Power of Hydrogen Peroxide: As cancer cells are more susceptible than normal cells to increased levels of hydrogen peroxide, we believe the conversion of radiation-generated superoxide to hydrogen peroxide by our selective dismutase mimetics can improve outcomes for patients who receive radiation ...
Manufactured by:IMB Dx, Inc. based inSeoul, SOUTH KOREA
The AlphaLiquid® platform is being widely applied in translational research to empower our understanding of tumor evolution, response to therapy and resistance mechanisms, as well as to provide insights on the clinical value of ctDNA analysis in precision ...
by:Lucence Health Inc. based inPalo Alto, CALIFORNIA (USA)
LiquidHALLMARK® is an ultrasensitive next-generation sequencing assay for genomic profiling of a patient’s unique cancer. By requiring only a single blood sample, LiquidHALLMARK provides important information for cancer care especially when tissue by invasive biopsy is insufficient or ...
Manufactured by:Kura Oncology, Inc. based inSan Diego, CALIFORNIA (USA)
Kura Oncology’s clinical trial programs represent the next step toward our goal of realizing the full potential of precision medicine. Our investigational trials are studying innovative therapeutic candidates with the potential to help patients with certain cancers live better, longer lives. ...
Manufactured by:Lupin Limited based inMumbai, INDIA
The NDDD team has developed a pipeline of highly differentiated and innovative new chemical entities in focused therapeutic areas of Oncology, Immunology and Metabolic ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
A key step in drug discovery is target identification—identifying "druggable" biological targets. After a target is identified, it must be validated to demonstrate the functional relationship between the target and disease phenotype while ensuring safety. The drug discovery process is lengthy and costly, but good target validation increases the likelihood of developing effective drugs and ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Biosimilars are biological products that are highly similar to an approved original biological drug (reference or brand drug) without any clinically meaningful differences in quality, safety, or efficacy compared to those approved. Biosimilars typically enter the market after the patent protection period of the original drug has expired, providing a more cost-effective treatment ...
Manufactured by:Cloud-Clone Corp. based inKaty, TEXAS (USA)
These include antisense and antigene drugs, antibody-based drugs, cytokines and protein drugs, mass screening of chemical drugs in vitro and vivo as well. It applies to the study of preclinical validity at home and ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
The inauguration of monoclonal antibodies (mAbs), derived from mice, were immunogenic in humans. These molecules were first synthesized in 1975 by Georges Köhler and César Milstein through the use of hybridoma technology. Later, in 1984, another milestone was achieved with the production of chimeric human antibodies via recombinant DNA technology. Hybridoma technology facilitates the creation of ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Prostanoids, also known as eicosanoids, are a family of signaling molecules produced and secreted by various types of cells under both normal and pathological conditions. In the human body, these metabolites are excreted into body fluids such as plasma and urine. The precursors of prostanoids are 20-carbon polyunsaturated fatty acids (PUFAs) like arachidonic acid (C20:4), which are esterified in ...
Manufactured by:XILIS, Inc. based inDurham, NORTH CAROLINA (USA)
Xilis’ rapid and scalable patient-derived MicroOrganoSphere (MOS) technology platform enhances precision medicine and pharmaceutical drug discovery and development. Compared to conventional patient-derived models, MOS provides faster, higher-throughput, and greater cost savings, as well as more predictive and accurate results. MOS can be used in large-scale pharmacogenomic studies that are ...